106 related articles for article (PubMed ID: 29374688)
1. Fluorescence-guided Surgery with Splenic Preservation Prevents Tumor Recurrence in an Orthotopic Nude-mouse Model of Human Pancreatic Cancer.
Hwang HK; Kang CM; Lee SH; Murakami T; Kiyuna T; Kim SH; Hoffman RM; Bouvet M
Anticancer Res; 2018 Feb; 38(2):665-670. PubMed ID: 29374688
[TBL] [Abstract][Full Text] [Related]
2. Ratiometric activatable cell-penetrating peptides label pancreatic cancer, enabling fluorescence-guided surgery, which reduces metastases and recurrence in orthotopic mouse models.
Metildi CA; Felsen CN; Savariar EN; Nguyen QT; Kaushal S; Hoffman RM; Tsien RY; Bouvet M
Ann Surg Oncol; 2015; 22(6):2082-7. PubMed ID: 25319581
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic mouse models.
Hiroshima Y; Maawy A; Zhang Y; Sato S; Murakami T; Yamamoto M; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
PLoS One; 2014; 9(6):e99977. PubMed ID: 24924955
[TBL] [Abstract][Full Text] [Related]
4. Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.
Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Katz MH; Fleming JB; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
PLoS One; 2014; 9(12):e114310. PubMed ID: 25463150
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC).
Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
Pancreatology; 2015; 15(3):295-301. PubMed ID: 25800176
[TBL] [Abstract][Full Text] [Related]
6. Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgery.
Yano S; Hiroshima Y; Maawy A; Kishimoto H; Suetsugu A; Miwa S; Toneri M; Yamamoto M; Katz MH; Fleming JB; Urata Y; Tazawa H; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Cancer Gene Ther; 2015 Jul; 22(7):344-50. PubMed ID: 26088297
[TBL] [Abstract][Full Text] [Related]
7. Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreatic Cancer Therapy in an Orthotopic Mouse Model.
Nishino H; Turner MA; Amirfakhri S; Lwin TM; Hosseini M; Singer BB; Hoffman RM; Bouvet M
Ann Surg Oncol; 2023 Jan; 30(1):618-625. PubMed ID: 36057899
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models.
Metildi CA; Kaushal S; Hardamon CR; Snyder CS; Pu M; Messer KS; Talamini MA; Hoffman RM; Bouvet M
J Am Coll Surg; 2012 Jul; 215(1):126-35; discussion 135-6. PubMed ID: 22632917
[TBL] [Abstract][Full Text] [Related]
10. Splenectomy is associated with an aggressive tumor growth pattern and altered host immunity in an orthotopic syngeneic murine pancreatic cancer model.
Hwang HK; Murakami T; Kiyuna T; Kim SH; Lee SH; Kang CM; Hoffman RM; Bouvet M
Oncotarget; 2017 Oct; 8(51):88827-88834. PubMed ID: 29179479
[TBL] [Abstract][Full Text] [Related]
11. Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice.
Hiroshima Y; Maawy A; Sato S; Murakami T; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
J Surg Res; 2014 Apr; 187(2):510-7. PubMed ID: 24373959
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence-guided surgery of human prostate cancer experimental bone metastasis in nude mice using anti-CEA DyLight 650 for tumor illumination.
Miwa S; De Magalhães N; Toneri M; Zhang Y; Cao W; Bouvet M; Tsuchiya H; Hoffman RM
J Orthop Res; 2016 Apr; 34(4):559-65. PubMed ID: 26135883
[TBL] [Abstract][Full Text] [Related]
13. Advantages of fluorescence-guided laparoscopic surgery of pancreatic cancer labeled with fluorescent anti-carcinoembryonic antigen antibodies in an orthotopic mouse model.
Metildi CA; Kaushal S; Luiken GA; Hoffman RM; Bouvet M
J Am Coll Surg; 2014 Jul; 219(1):132-41. PubMed ID: 24768506
[TBL] [Abstract][Full Text] [Related]
14. Eradication of osteosarcoma by fluorescence-guided surgery with tumor labeling by a killer-reporter adenovirus.
Yano S; Miwa S; Kishimoto H; Urata Y; Tazawa H; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
J Orthop Res; 2016 May; 34(5):836-44. PubMed ID: 26479501
[TBL] [Abstract][Full Text] [Related]
15. Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models.
Maawy AA; Hiroshima Y; Zhang Y; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
J Surg Res; 2015 Jul; 197(1):5-11. PubMed ID: 25799527
[TBL] [Abstract][Full Text] [Related]
16. Improved disease-free survival and overall survival after fluorescence-guided surgery of liver metastasis in an orthotopic nude mouse model.
Murakami T; Hiroshima Y; Zhang Y; Bouvet M; Chishima T; Tanaka K; Endo I; Hoffman RM
J Surg Oncol; 2015 Aug; 112(2):119-24. PubMed ID: 26266663
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral targeting of malignant melanoma for fluorescence-guided surgery prevents recurrence in orthotopic nude-mouse models.
Yano S; Takehara K; Kishimoto H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Oncotarget; 2016 Apr; 7(14):18558-72. PubMed ID: 26701857
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence-guided surgery of retroperitoneal-implanted human fibrosarcoma in nude mice delays or eliminates tumor recurrence and increases survival compared to bright-light surgery.
Uehara F; Hiroshima Y; Miwa S; Tome Y; Yano S; Yamamoto M; Matsumoto Y; Maehara H; Tanaka K; Bouvet M; Kanaya F; Hoffman RM
PLoS One; 2015; 10(2):e0116865. PubMed ID: 25710463
[TBL] [Abstract][Full Text] [Related]
19. Targeting tumors with a killer-reporter adenovirus for curative fluorescence-guided surgery of soft-tissue sarcoma.
Yano S; Miwa S; Kishimoto H; Uehara F; Tazawa H; Toneri M; Hiroshima Y; Yamamoto M; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Oncotarget; 2015 May; 6(15):13133-48. PubMed ID: 26033451
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]